Charles River Raises 2026 Revenue and Non-GAAP EPS Guidance, Shares Jump 8.8%
CRL sits 75% above its 52-week low of $144.26.
Summary
Charles River posted Q2 revenue of $1.00 billion and non-GAAP EPS of $3.02, beating estimates and raising its full-year guidance. Organic revenue growth turned slightly positive at 0.1%, reversing prior declines. Non-GAAP EPS guidance was lifted to $11.15-$11.45 from $10.80-$11.30, while GAAP EPS guidance was slashed to $3.05-$3.35 due to divestiture losses. The market focused on the core business recovery, sending shares up 8.8% pre-market to $254.73. This follows the earlier Reuters report on the beat and raise, but adds the GAAP guidance cut and the sharp price reaction.
At the time of this announcement, CRL was trading at $253.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.3B. The 52-week trading range was $144.26 to $242.73. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.